Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Monopar Therapeutics (MNPR) Exchange Rate Effect (2018 - 2020)

Monopar Therapeutics (MNPR) has disclosed Exchange Rate Effect for 3 consecutive years, with $2273.0 as the latest value for Q4 2020.

  • Quarterly Exchange Rate Effect rose 85.55% to $2273.0 in Q4 2020 from the year-ago period, while the trailing twelve-month figure was $3334.0 through Dec 2020, up 138.89% year-over-year, with the annual reading at $97266.0 for FY2025, 19589.47% up from the prior year.
  • Exchange Rate Effect hit $2273.0 in Q4 2020 for Monopar Therapeutics, up from $2205.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $2897.0 in Q2 2020 to a low of -$8739.0 in Q3 2019.
  • Historically, Exchange Rate Effect has averaged -$694.18 across 3 years, with a median of -$11.0 in 2018.
  • Biggest YoY gain for Exchange Rate Effect was 11236.36% in 2019; the steepest drop was 974.91% in 2019.
  • Year by year, Exchange Rate Effect stood at -$11.0 in 2018, then skyrocketed by 11236.36% to $1225.0 in 2019, then soared by 85.55% to $2273.0 in 2020.
  • Business Quant data shows Exchange Rate Effect for MNPR at $2273.0 in Q4 2020, $2205.0 in Q3 2020, and $2897.0 in Q2 2020.